Opportunities for molecular epidemiological research on ductal carcinoma in-situ and breast carcinogenesis: Interdisciplinary approaches

Mark E. Sherman, Carolyn Mies, Gretchen L. Gierach

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

Most invasive breast cancers arise from ductal carcinoma in-situ (DCIS), a non-obligate precursor of invasive breast cancer. Given that the natural history of individual DCIS lesions is unpredictable, many women with DCIS receive extensive treatments, which may include surgery, radiation and endocrine therapy, even though many of these lesions may have limited potential to progress to invasion and metastasize. In contrast to valid concerns about overtreatment, the fact that invasive breast cancers outnumber DCIS lesions by more than three-to-one, suggests that many cancer precursors (particularly DCIS, but LCIS also) progress to invasion prior to detection. Thus, DCIS poses a dual problem of overdiagnosis among some women and failure of early detection among others. These concerns are heightened by the multifold increase in rates of DCIS in conjunction with widespread use of mammographic screening and access to outpatient radiologically-guided biopsies. Accordingly, methods are needed to both specifically detect and identify DCIS lesions with potential to progress to invasive cancer and to discover techniques to triage and conservatively manage indolent cases of DCIS.

Original languageEnglish (US)
Pages (from-to)105-116
Number of pages12
JournalBreast Disease
Volume34
Issue number3
DOIs
StatePublished - 2014

Fingerprint

Carcinoma, Intraductal, Noninfiltrating
Carcinogenesis
Breast
Research
Breast Neoplasms
Triage
Neoplasms
Outpatients
Radiotherapy
Biopsy

Keywords

  • biomarkers
  • Ductal carcinoma in-situ
  • epidemiology
  • lobular carcinoma in-situ
  • pathogenesis

ASJC Scopus subject areas

  • Medicine(all)
  • Oncology
  • Cancer Research

Cite this

Opportunities for molecular epidemiological research on ductal carcinoma in-situ and breast carcinogenesis : Interdisciplinary approaches. / Sherman, Mark E.; Mies, Carolyn; Gierach, Gretchen L.

In: Breast Disease, Vol. 34, No. 3, 2014, p. 105-116.

Research output: Contribution to journalArticle

@article{cc4ca4d09a8c48e98cd3239514d69588,
title = "Opportunities for molecular epidemiological research on ductal carcinoma in-situ and breast carcinogenesis: Interdisciplinary approaches",
abstract = "Most invasive breast cancers arise from ductal carcinoma in-situ (DCIS), a non-obligate precursor of invasive breast cancer. Given that the natural history of individual DCIS lesions is unpredictable, many women with DCIS receive extensive treatments, which may include surgery, radiation and endocrine therapy, even though many of these lesions may have limited potential to progress to invasion and metastasize. In contrast to valid concerns about overtreatment, the fact that invasive breast cancers outnumber DCIS lesions by more than three-to-one, suggests that many cancer precursors (particularly DCIS, but LCIS also) progress to invasion prior to detection. Thus, DCIS poses a dual problem of overdiagnosis among some women and failure of early detection among others. These concerns are heightened by the multifold increase in rates of DCIS in conjunction with widespread use of mammographic screening and access to outpatient radiologically-guided biopsies. Accordingly, methods are needed to both specifically detect and identify DCIS lesions with potential to progress to invasive cancer and to discover techniques to triage and conservatively manage indolent cases of DCIS.",
keywords = "biomarkers, Ductal carcinoma in-situ, epidemiology, lobular carcinoma in-situ, pathogenesis",
author = "Sherman, {Mark E.} and Carolyn Mies and Gierach, {Gretchen L.}",
year = "2014",
doi = "10.3233/BD-130359",
language = "English (US)",
volume = "34",
pages = "105--116",
journal = "Breast Disease",
issn = "0888-6008",
publisher = "IOS Press",
number = "3",

}

TY - JOUR

T1 - Opportunities for molecular epidemiological research on ductal carcinoma in-situ and breast carcinogenesis

T2 - Interdisciplinary approaches

AU - Sherman, Mark E.

AU - Mies, Carolyn

AU - Gierach, Gretchen L.

PY - 2014

Y1 - 2014

N2 - Most invasive breast cancers arise from ductal carcinoma in-situ (DCIS), a non-obligate precursor of invasive breast cancer. Given that the natural history of individual DCIS lesions is unpredictable, many women with DCIS receive extensive treatments, which may include surgery, radiation and endocrine therapy, even though many of these lesions may have limited potential to progress to invasion and metastasize. In contrast to valid concerns about overtreatment, the fact that invasive breast cancers outnumber DCIS lesions by more than three-to-one, suggests that many cancer precursors (particularly DCIS, but LCIS also) progress to invasion prior to detection. Thus, DCIS poses a dual problem of overdiagnosis among some women and failure of early detection among others. These concerns are heightened by the multifold increase in rates of DCIS in conjunction with widespread use of mammographic screening and access to outpatient radiologically-guided biopsies. Accordingly, methods are needed to both specifically detect and identify DCIS lesions with potential to progress to invasive cancer and to discover techniques to triage and conservatively manage indolent cases of DCIS.

AB - Most invasive breast cancers arise from ductal carcinoma in-situ (DCIS), a non-obligate precursor of invasive breast cancer. Given that the natural history of individual DCIS lesions is unpredictable, many women with DCIS receive extensive treatments, which may include surgery, radiation and endocrine therapy, even though many of these lesions may have limited potential to progress to invasion and metastasize. In contrast to valid concerns about overtreatment, the fact that invasive breast cancers outnumber DCIS lesions by more than three-to-one, suggests that many cancer precursors (particularly DCIS, but LCIS also) progress to invasion prior to detection. Thus, DCIS poses a dual problem of overdiagnosis among some women and failure of early detection among others. These concerns are heightened by the multifold increase in rates of DCIS in conjunction with widespread use of mammographic screening and access to outpatient radiologically-guided biopsies. Accordingly, methods are needed to both specifically detect and identify DCIS lesions with potential to progress to invasive cancer and to discover techniques to triage and conservatively manage indolent cases of DCIS.

KW - biomarkers

KW - Ductal carcinoma in-situ

KW - epidemiology

KW - lobular carcinoma in-situ

KW - pathogenesis

UR - http://www.scopus.com/inward/record.url?scp=84903627507&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84903627507&partnerID=8YFLogxK

U2 - 10.3233/BD-130359

DO - 10.3233/BD-130359

M3 - Article

C2 - 24225267

AN - SCOPUS:84903627507

VL - 34

SP - 105

EP - 116

JO - Breast Disease

JF - Breast Disease

SN - 0888-6008

IS - 3

ER -